Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Plasma psilocin critically determines behavioral and neurobiological effects of psilocybin

This is a preview of subscription content

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    Rucker JJH, Iliff J, Nutt DJ. Psychiatry & the psychedelic drugs. Past, present & future. Neuropharmacology. 2018;142:200–18.

    CAS  Article  Google Scholar 

  2. 2.

    Hasler F, Bourquin D, Brenneisen R, Bär T, Vollenweider FX. Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man. Pharm Acta Helv. 1997;72:175–84.

    CAS  Article  Google Scholar 

  3. 3.

    Rickli A, Moning OD, Hoener MC, Liechti ME. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens. Eur Neuropsychopharmacol. 2016;26:1327–37.

    CAS  Article  Google Scholar 

  4. 4.

    Vollenweider FX, Vollenweider-Scherpenhuyzen MF, Bäbler A, Vogel H, Hell D. Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. Neuroreport 1998;9:3897–902.

    CAS  Article  Google Scholar 

  5. 5.

    Madsen MK, Fisher PM, Burmester D, Dyssegaard A, Stenbæk DS, Kristiansen S, et al. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels. Neuropsychopharmacology. 2019;44:1328–34.

    CAS  Article  PubMed  Google Scholar 

Download references


We thank Drs. Patrick M. Fisher and Dea S. Stenbæk for important contributions to the psilocybin research program at our lab, including Madsen et al. [5].

Author information




MKM and GMK wrote the present manuscript and were the foremost contributors to Madsen et al. [5].

Corresponding author

Correspondence to Gitte M. Knudsen.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Madsen, M.K., Knudsen, G.M. Plasma psilocin critically determines behavioral and neurobiological effects of psilocybin. Neuropsychopharmacol. 46, 257–258 (2021).

Download citation


Quick links